Total Funding
44
39
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
154638
Yield10 Bioscience develops crop yield improvement solutions using advanced genetic engineering and synthetic biology techniques.
Sarah P. Cecil: General CounselPast Role: Vertex Pharmaceuticals, Corporate Counsel
Oliver P. Peoples: President and CEOPast Role: Yield10 Bioscience, Director of Research and Vice President
About the Company
Yield10 Bioscience is a biotechnology company that specializes in developing innovative crop yield improvement solutions using advanced genetic engineering and synthetic biology techniques. The company focuses on creating proprietary traits and technologies that can enhance the productivity and nutritional profile of various crops, with an emphasis
on oilseed crops and other specialty crops. Yield10 Bioscience employs cutting-edge biotechnological tools to develop and test their plant traits and technologies. This includes utilizing techniques like gene editing, genome engineering, and metabolic engineering to introduce specific genetic modifications into plants that can lead to desired traits.
